What's different? This time the ISO 13485 certification satisfies a substantial part of annex 1 to 5 of the Council Directive for CE marking. The literature has ample studies on P32 radiation to treat tumors. More recent advances in the proposed technique of injection for the device have been shown to be safe. The more widely recognised advantages of Brachytherapy over external radiation. The pioneering work of Sirtex in expanding the field of Brachytherapy. OSL has employed a suitable expert to provide medical support and clinical studies .The company has got its supply chain, scientific and regulatory affairs. functions in place. All needed to support a CE application. Sirtex has substantially provided post marketing clinical studies. OSL will be do the same.
OSL Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)